Logo for Impel Pharmaceuticals Inc

Impel Pharmaceuticals Investor Relations Material

Latest events

Logo for Impel Pharmaceuticals Inc

Q1 2023

Impel Pharmaceuticals
Logo for Impel Pharmaceuticals

Q3 2023

14 Nov, 2023
Logo for Impel Pharmaceuticals

Q2 2023

18 Aug, 2023
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Impel Pharmaceuticals Inc

Access all reports
Impel Pharmaceuticals Inc is a biopharmaceutical company that develops intranasal drug delivery treatments for central nervous system disorders. The company’s delivery platform enables rapid and targeted administration of therapeutics for conditions such as migraines and Parkinson’s disease. It focuses on commercializing treatments through healthcare provider networks. Impel Pharmaceuticals Inc is headquartered in Seattle, Washington, and its shares are listed on the NASDAQ.